Faricimab Antibody
Faricimab is a bispecific antibody targeting Ang-2 and VEGF-A. It demonstrates efficacy in preclinical models of retinal disease, reducing vascular leakage, cell death, and inflammation following ischemia/reperfusion injury and in studies of choroidal neovascularization.
Product Specifications
Product Name Alternative
Faricimab, RG7716, RG-7716, RG 7716
Target
VEGFR, RAAS
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Metabolism Research, Signal Transduction
Concentration
17.15 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
